Clinical trial Recruiting at 3 sites Interventional Ages 18 to 85

SwissNeuroRehab HDHI — High-Dose, High-Intensity Stroke Rehabilitation Program

Official title: SwissNeuroRehab - High Dose High Intensity Neurorehabilitation Along the Continuum of Care

Run by Centre Hospitalier Universitaire Vaudois · NCT07427511 · Data updated 2026-11-12

This program tests whether a structured, device-supported high-dose, high-intensity therapy plan can improve motor recovery for adults with subacute or chronic stroke across inpatient, outpatient, and home settings in Switzerland.

More Stroke trials

Quick facts

Study typeInterventional
Ages18 Years to 85 Years
SexAll
Enrollment120 (estimated)
SponsorCentre Hospitalier Universitaire Vaudois
Academic / other
Locations5 sites (Vitznau, Canton of Lucerne and 4 other locations)
StatusRecruiting
StartedFebruary 10, 2026
Main results expectedMay 31, 2028
Study endsMay 31, 2028
Registry record updatedMarch 10, 2026
Trial IDNCT07427511 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–85 with a confirmed ischemic or hemorrhagic stroke more than 7 days prior who can sit unassisted, have motor difficulties in an arm or leg, and are willing to commit to the program and assessments are the ideal candidates.

Probably not a fit

Patients with severe cognitive impairment, uncontrolled seizures, severe neglect, plegia of the affected limb, or other medical conditions that limit safe participation are unlikely to benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a multicentre, non-randomised interventional feasibility project run within the SwissNeuroRehab network that implements a structured high-dose, high-intensity (HDHI) therapy pathway using CE‑marked digital neurorehabilitation tools. The pathway is designed for delivery across inpatient, outpatient, and home environments at several Swiss rehabilitation centres. Adults with ischemic or hemorrhagic stroke who can sit unassisted and have upper and/or lower limb motor difficulties are enrolled and asked to commit to a daily training dose and program length. Feasibility measures and preliminary clinical outcomes are collected at the start and end of the program to inform wider implementation.

Why it matters

Potential benefit: If successful, the program could accelerate and increase motor recovery and daily-function gains after stroke by delivering a higher, technology-supported therapy dose across care settings.

How similar studies have gone: Previous research on high-dose, high-intensity and device-assisted neurorehabilitation has shown promising motor improvements, though large-scale real-world implementation across care settings remains less established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 18-85 years.
* Confirmed diagnosis of stroke (ischemic or hemorrhagic) \>7 days ago
* Be able to sit unassisted
* Able and willing to give informed consent
* Have motor difficulties of the Upper Extremity and/or Lower Extremity
* Willing to commit to program length \& daily training dose
* Willing to have assessments at start and end of program
* Signed informed consent

Exclusion Criteria:

* Severe cognitive impairment
* Uncontrolled seizure disorder or epilepsy - clinician's judgement)
* Any medical condition that would compromise their safety (inability to communicate, vision or hearing impairment, heart condition that limits participation in exercise) and tolerability (cardiac contraindications)
* Pain that would limit rehabilitation dose
* Severe apraxia
* Severe memory disorder
* Severe hemispatial neglect
* Plegia of the affected limb

Where it's running

  • Klinik Valens
    Valens, Canton of St. Gallen, Switzerland
    Recruiting
  • Centre hospitalier universitaire Vaudois
    Lausanne, Canton of Vaud, Switzerland
    Recruiting
  • Swiss Réhabilitation Sàrl
    Sullens, Canton of Vaud, Switzerland
    Recruiting
  • Lake Lucerne Institute
    Vitznau, Canton of Lucerne, Switzerland
    Not yet recruiting
  • Universitätspital Zürich
    Zurich, Canton of Zurich, Switzerland
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.